Showing 1 - 10 of 207
higher probability to receive the brand-name drug due to their lower marginal utility of income. Today's administered …. -- Physician dispensing ; prescribing behavior ; generics ; brand-name drugs …
Persistent link: https://www.econbiz.de/10003900934
Persistent link: https://www.econbiz.de/10003344907
Persistent link: https://www.econbiz.de/10012817421
With the ongoing trade normalisation process between India and Pakistan, opportunities to integrate have opened up between both countries. The pharmaceutical sector is crucial to health issues in developing economies and would be an ideal segment to focus on in improving trade relations between...
Persistent link: https://www.econbiz.de/10010404687
Persistent link: https://www.econbiz.de/10000996532
Persistent link: https://www.econbiz.de/10000997856
Persistent link: https://www.econbiz.de/10011981115
Persistent link: https://www.econbiz.de/10012102580
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
Persistent link: https://www.econbiz.de/10011765364